PML with dimethyl fumarate-No role for natalizumab?

被引:0
|
作者
Berger, Joseph R. [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
关键词
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; MULTIPLE-SCLEROSIS; JC VIRUS; EXPRESSION;
D O I
10.1177/1352458519872897
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1686 / 1687
页数:2
相关论文
共 50 条
  • [1] PML with dimethyl fumarate-No convincing case against natalizumab
    Diebold, Martin
    Altersberger, Valerian
    Decard, Bernhard F.
    Kappos, Ludwig
    Derfuss, Tobias
    Lorscheider, Johannes
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (12) : 1687 - 1688
  • [3] PML in Patients Treated with Dimethyl Fumarate
    van Kester, Marloes S.
    Bavinck, Jan N. Bouwes
    Quint, Koen D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (06): : 583 - 584
  • [5] PML in Patients Treated with Dimethyl Fumarate REPLY
    Nieuwkamp, Dennis J.
    Murk, Jean-Luc
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (06): : 584 - 584
  • [6] More on PML in Patients Treated with Dimethyl Fumarate
    Reich, Kristian
    Hartung, Hans-Peter
    Lebwohl, Mark
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (03): : 294 - 295
  • [7] PML in a Patient with Lymphocytopenia Treated with Dimethyl Fumarate
    Rosenkranz, Thorsten
    Novas, Mark
    Terborg, Christoph
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (15): : 1476 - 1478
  • [8] More on PML in Patients Treated with Dimethyl Fumarate REPLY
    Balak, Deepak
    Hajdarbegovic, Enes
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (03): : 295 - 295
  • [10] Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment
    Vollmer, Brandi L.
    Nair, Kavita V.
    Sillau, Stefan
    Corboy, John R.
    Vollmer, Timothy
    Alvarez, Enrique
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (02): : 252 - 262